MCL1 and neoplasm: In the Mito-FF treatment group, the tumor tissue exhibited a significant increase in the pro-apoptotic marker, cleaved PARP, compared to the control group, while the anti-apoptotic marker, Mcl-1, showed a significant decrease (p < 0.05) (Figure 4D).